Bevacizumab/sirolimusLack of efficacy and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1913卷 / 1期

关键词：

D O I：

10.1007/s40278-022-18268-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：118 / 118

相关论文

共 50 条

[1] Itraconazole/sirolimusLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1891 (1) : 177 - 177
[2] Antidiarrhoeals/Bevacizumab/SteroidsLack of efficacy and off-label use: case report
Reactions Weekly, 2025, 2040 (1) : 77 - 77
[3] Bevacizumab/povidone-iodineEndophthalmitis following off-label use of bevacizumab and lack of efficacy: case report
Reactions Weekly, 2025, 2046 (1) : 79 - 79
[4] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1866 (1) : 47 - 47
[5] OsimertinibLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1949 (1) : 349 - 349
[6] RituximabLack of efficacy in off-label use: case report
Reactions Weekly, 2023, 1946 (1) : 492 - 492
[7] ItraconazoleLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1911 (1) : 254 - 254
[8] DenosumabLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1909 (1) : 216 - 216
[9] NifedipineLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1918 (1) : 386 - 386
[10] TocilizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1954 (1) : 409 - 409

← 1 2 3 4 5 →